Status:
COMPLETED
Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367)
Lead Sponsor:
Organon and Co
Conditions:
Asthma
Allergic Rhinitis
Eligibility:
All Genders
2-14 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to assess real-world effectiveness of montelukast in children (2 to 14 years) with asthma and allergic rhinitis.
Eligibility Criteria
Inclusion
- Between 2 and 14 years old
- Diagnosed with asthma, classified as mild persistent asthma according to Global Initiative Asthma Guidelines (GINA)
- Diagnosed with comorbid allergic rhinitis
Exclusion
- Patients with suspected sinus infection
- Prior treatment with high dose inhaled corticosteroid requiring a dose higher than beclomethasone dipropionate 400 ug per day, or equivalent, other medications used in severe cases
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2007
Estimated Enrollment :
191 Patients enrolled
Trial Details
Trial ID
NCT00442559
Start Date
January 1 2005
End Date
October 1 2007
Last Update
May 13 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.